Vontier Reports Fourth Quarter and Full Year 2022 Results; Initiates 2023 Guidance
Go back to Vontier Reports Fourth Quarter and Full Year 2022 Results; Initiates 2023 Guidance| Savient Pharmaceuticals, Inc. (NYSE: VNT) | Delayed: 31.36 -0.46 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.82 | 52 Week High | $9.92 | |||
| Open | $31.78 | 52 Week Low | $9.10 | |||
| Day High | $31.93 | P/E | N/A | |||
| Day Low | $31.31 | EPS | $-0.94 | |||
| Volume | 2,881,873 | |||||
